BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191203
DTEND;VALUE=DATE:20191206
DTSTAMP:20260515T041839
CREATED:20190909T090526Z
LAST-MODIFIED:20190909T101000Z
UID:22341-1575331200-1575590399@www.pharmajournalist.com
SUMMARY:Oncolytic Virotherapy Summit 2019
DESCRIPTION:Now in its 5th year\, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 days of in-depth cutting-edge case studies and the highest calibre of industry discussions\, The OV Summit will provide the roadmap to oncolytic virotherapy success. \nHear from pharma and biotech companies of all sizes\, as well as clinicians and leading academics for a complete picture of the current challenges and opportunities. Discover the development of oncolytic viruses that engage the immune system for long-term treatment and management of cancers. \nTo learn more and to register online\, visit: http://bit.ly/2kmZGQh
URL:https://www.pharmajournalist.com/event/oncolytic-virotherapy-summit-2019/
LOCATION:Westin Boston Waterfront\, 425 Summer St\, Boston\, MA 02210
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191203
DTEND;VALUE=DATE:20191206
DTSTAMP:20260515T041839
CREATED:20191101T093844Z
LAST-MODIFIED:20191101T093844Z
UID:23150-1575331200-1575590399@www.pharmajournalist.com
SUMMARY:3rd Microbiome Movement – Gut-Brain Axis Summit
DESCRIPTION:The 3rd Microbiome Movement – Gut-Brain Axis Summit is returning to Boston this December and will unite pioneering industry and academic researchers to establish the mechanistic pathways contributing to neurological disorder manifestation\, overcome the scientific and translational challenges of working in the gut-brain setting and capitalize on this therapeutic opportunity. \n \nThis meeting provides the opportunity for you to: \n\nDiscover pioneering preclinical data implicating metabolic\, immune-mediated and enteroendocrine pathways in CNS disease development\nExplore translational approaches that are moving microbiome gut-brain axis science from association to causation\nLearn about critical considerations for microbiome clinical trials in the neurological and mental health setting to inform symptom and treatment management\nRealize the potential of microbial profiles as a biomarker for patient stratification to maximize the efficacy of already existing drugs for neurological disease\nUncover the relatively untapped commercial opportunity held by nutritional and therapeutic products for neurological and mental health\n\nThere is no question that the early market activity in the microbiome gut-brain axis space is critical in shaping its success. Join us to discover the microbiome science contributing to neurological disease and develop the next generation of microbiome-targeted products for improved neurological and mental health outcomes. \nFind out more here: https://ter.li/t9gsy7
URL:https://www.pharmajournalist.com/event/3rd-microbiome-movement-gut-brain-axis-summit/
LOCATION:Boston\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:katie.jacobs@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191206
DTSTAMP:20260515T041839
CREATED:20190410T071442Z
LAST-MODIFIED:20191008T060245Z
UID:20275-1575417600-1575590399@www.pharmajournalist.com
SUMMARY:HR Life Sciences
DESCRIPTION:With the rapid rise of digital technology and shifts within the larger healthcare industry\, the need to find new talent that can drive innovation has never been more critical. HR Life Sciences is specifically designed for senior HR professionals at the nation’s leading Pharmaceutical\, Biotech and Medical Device companies. You’ll discover the tools\, insights\, innovations\, and cutting-edge solutions needed to evolve your hiring strategies in a rapidly changing life science industry. Register now with code PHARMAJ20 and receive a 20% discount. \n \nAt HR Life Sciences\, you’ll learn how to: \n\nRefine your talent sourcing to meet shrinking\, highly competitive talent pools\nRetain and develop top talent in an ever-changing market full of mergers & acquisitions\nKeep up with new and emerging employee engagement & development trends\nStay ahead of the curve with new HR technologies and tools suited to your workforce\nMaintain HR’s position as a visible business partner & thought-leader
URL:https://www.pharmajournalist.com/event/hr-life-sciences/
LOCATION:San Diego\, CA
ORGANIZER;CN="Worldwide Business Research":MAILTO:hrlifesciences@wbresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191204
DTEND;VALUE=DATE:20191207
DTSTAMP:20260515T041839
CREATED:20190930T095204Z
LAST-MODIFIED:20190930T104919Z
UID:22646-1575417600-1575676799@www.pharmajournalist.com
SUMMARY:8th annual PREDiCT: Tumour Models London
DESCRIPTION:The 8th annual PREDiCT: Tumour Models London Summit will return this December with a new speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology\, model requirements\, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts\, including Merck\, MedImmune\, Takeda\, Roche\, AstraZeneca and more for practical insights. \nTo learn more about 8th annual PREDiCT: Tumour Models London and to register online\, visit https://ter.li/6ge5rc
URL:https://www.pharmajournalist.com/event/8th-annual-predict-tumour-models-london/
LOCATION:London\, UK\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191205
DTEND;VALUE=DATE:20191207
DTSTAMP:20260515T041839
CREATED:20190531T111302Z
LAST-MODIFIED:20190614T081716Z
UID:21011-1575504000-1575676799@www.pharmajournalist.com
SUMMARY:SMi’s Inaugural Conference: Respiratory Drug Delivery 2019
DESCRIPTION:SMi are pleased to announce the launch of the Respiratory Drug Delivery conference as part of the newly branded Asthma and COPD series\, which will be held in London on the 5th – 6th December 2019. \n \nWith the rising prevalence of respiratory disease such as Asthma\, cystic fibrosis and COPD\, this group of diseases are now amongst the leading cause of death\, affecting over 500 million adults and children worldwide. Lung cancer now accounts for over 50% of all respiratory disease related deaths in Europe\, yet little work is being done to reduce this high mortality rate. \nOpportunities for drug development has effectively resulted in the global pulmonary and respiratory drug delivery market expecting to reach 64 billion USD (6.7% CAGR) by 2025. However\, the unmet medical needs of respiratory diseases sufferers remain. \nJoin us this year as SMi aim to bring together clinical researchers\, respiratory drug manufacturers and solution providers to discuss the current research and developments in providing appropriate long-term treatments that adhere to patient’s needs\, analysing the success of digital media devices and connective health technology in aiding the diagnosis of severe asthma and COPD. This year will also investigate the developing issues surrounding pulmonary and nasal combination product design. \nBenefits of attending: \n\nAssessing how to transform disease management through drug combinations\, devices and inhaled biological treatments\nEvaluating respiratory device design development and novel technologies such as nanoparticle-based drug delivery\nExploring digital connective inhalation to improve patient centricity\nReviewing the challenges around the pricing and reimbursement of respiratory drug products\n\nView the full agenda online: www.respiratorydrugdelivery.com/pharmajwl \nEarly bird rates: \n\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH SEPTEMBER AND SAVE £100\n\nSOCIAL MEDIA HANDLES \nTwitter: @SMiPharm #SMirespiratory\nLinkedIn: follow our company page – search ‘SMi Pharma’ \nContact \n+44 (0) 20 7827 6088\nhsidhu@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/respiratory-drug-delivery-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
END:VCALENDAR